Trial Profile
Double-blind, multicenter, study comparing the efficacy and safety of OMS103HP.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2011
Price :
$35
*
At a glance
- Drugs Amitriptyline/oxymetazoline/ketoprofen (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Omeros Corporation
- 29 Jun 2011 Results were published in in the online version of Arthroscopy: The Journal of Arthroscopic and Related Surgery.
- 03 May 2010 Additional results presented in an Omeros Corporation media release.
- 31 Mar 2010 Results released in an Omeros Corporation media release.